Health Catalyst, Inc. (HCAT) insider trading
Health Catalyst, Inc. insiders have made 1 open-market purchase worth $105k since Sep 16, 2026, by 1 insider. The latest: Simeon Kohl (CEO) bought $105k, filed Sep 16, 2026, scored 30 out of 100.
Follow HCAT, freeOpen the live feed
A free account gets an alert the minute a new buy or sale is filed.
Insider purchases
| Filed | Insider | Stake | Score | Bought | 1 week | 1 month |
|---|---|---|---|---|---|---|
| Sep 16 Form 4 (opens sec.gov) |
Simeon KohlCEOCEO · Near 52-week low · Penny stock: hard to trade | +2% stake | 30 | $105k 59,000 at $1.79 |
−3.3% | −5.0% |
Track record (hypothetical): a week after the filing, these buys averaged −3.3% (0% up, 1 measured); a month after, −5.0% (0% up, 1 measured).
Insiders who bought HCAT
- Simeon Kohl CEO
Questions
Are insiders buying HCAT stock?
Yes. In the last 90 days, 1 open-market purchase was filed, worth $105k.
Who bought HCAT stock most recently?
Simeon Kohl, CEO, bought 59,000 shares for $105k (Form 4 (opens sec.gov), filed Sep 16, 2026).
How does InsiderBeacon score an insider buy?
Out of 100, from who bought, how much their stake grew, the size of the trade, whether other insiders bought within ten days, where the price sat in its 52-week range, and whether it was a first or a routine buy. The score is fixed when the filing arrives. The formula and the research behind it.
Insiders are also buying, same industry
Data as of Sep 16, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer